Long-term cardiac allograft survival in mice treated with malononitrilamide 715. 1998

K Gerauer, and S Maier, and K Emmanuilidis, and N Chambron, and N Zantl, and K Pfeffer, and C D Heidecke
Technische Universität München, Germany.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007555 Isoxazoles Azoles with an OXYGEN and a NITROGEN next to each other at the 1,2 positions, in contrast to OXAZOLES that have nitrogens at the 1,3 positions. Isoxazole
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009570 Nitriles Organic compounds containing the -CN radical. The concept is distinguished from CYANIDES, which denotes inorganic salts of HYDROGEN CYANIDE. Nitrile
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D000480 Alkynes Hydrocarbons with at least one triple bond in the linear portion, of the general formula Cn-H2n-2. Acetylenic Compounds,Alkyne,Acetylenes
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

K Gerauer, and S Maier, and K Emmanuilidis, and N Chambron, and N Zantl, and K Pfeffer, and C D Heidecke
December 1997, Transplantation proceedings,
K Gerauer, and S Maier, and K Emmanuilidis, and N Chambron, and N Zantl, and K Pfeffer, and C D Heidecke
January 1998, Transplant international : official journal of the European Society for Organ Transplantation,
K Gerauer, and S Maier, and K Emmanuilidis, and N Chambron, and N Zantl, and K Pfeffer, and C D Heidecke
February 1989, Proceedings of the National Academy of Sciences of the United States of America,
K Gerauer, and S Maier, and K Emmanuilidis, and N Chambron, and N Zantl, and K Pfeffer, and C D Heidecke
June 2003, Transplantation,
K Gerauer, and S Maier, and K Emmanuilidis, and N Chambron, and N Zantl, and K Pfeffer, and C D Heidecke
January 2006, Advances in chronic kidney disease,
K Gerauer, and S Maier, and K Emmanuilidis, and N Chambron, and N Zantl, and K Pfeffer, and C D Heidecke
March 1979, Lancet (London, England),
K Gerauer, and S Maier, and K Emmanuilidis, and N Chambron, and N Zantl, and K Pfeffer, and C D Heidecke
August 1998, Transplantation proceedings,
K Gerauer, and S Maier, and K Emmanuilidis, and N Chambron, and N Zantl, and K Pfeffer, and C D Heidecke
March 2006, Current atherosclerosis reports,
K Gerauer, and S Maier, and K Emmanuilidis, and N Chambron, and N Zantl, and K Pfeffer, and C D Heidecke
November 2020, Stem cell research & therapy,
K Gerauer, and S Maier, and K Emmanuilidis, and N Chambron, and N Zantl, and K Pfeffer, and C D Heidecke
February 2002, Therapeutic drug monitoring,
Copied contents to your clipboard!